SARA DOMBY: Open Payments
NPI 1841914348 · PENNINGTON GAP, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 29 payments from 9 companies in 2025. Trend: 2023 $215 · 2024 $303 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $139 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Amgen Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LifeVest, CAMZYOS, LEQVIO, REPATHA, ELIQUIS, Kerendia, VERQUVO, Rybelsus.
Industry payments across VA — which companies pay providers there.
